治疗双极性抑郁症的抗抑郁药:评论评论
Gustavo H Vázquez1,2, Ross J Baldessarini1,3
1International Consortium for Mood & Psychotic Disorders Research, Mailman Research Center, McLean Hospital, Belmont, MA, United States.
The international journal of neuropsychopharmacology
|February 18, 2025
概括
抗抑郁药 (ADs) 可能有效治疗双极性抑郁症,特别是与情绪稳定剂相结合时. 治疗比BD-1更安全的双相二极性障碍 (BD-2),需要适量剂量和密切监督.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 双极性抑郁症带来了重大治疗挑战,导致残疾和死亡率.
- 在双相抑郁症中使用抗抑郁药 (AD) 是有争议的,安全性和有效性不确定.
研究的目的:
- 审查关于治疗双相情感障碍 (BD) 中抑郁症的研究.
- 为了支持在BD中使用抗抑郁药的临床指南.
主要方法:
- 选择研究结果的系统审查.
- 专注于抗抑郁药物治疗双极性抑郁症.
主要成果:
- 抗抑郁药 (ADs) 在双极性抑郁症中显示出可能的有效性,与严重抑郁症可比.
- 治疗耐受性比BD-1更好,特别是在二极性情绪障碍 (BD-2) 中,特别是使用情绪稳定剂或抗精神病药物.
- 血清素再吸收抑制剂和布洛普是双极性抑郁症的首选抗药物,在有限的时间内适量服用.
结论:
- 对双极性抑郁症的最佳长期治疗需要进一步的研究.
- 急性抑郁症可以安全地管理ADs在中等剂量,结合情绪稳定剂或抗精神病药物.
- 在BD-2治疗比BD-1更安全,需要密切的临床监督.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
181
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
181
Mania and Antimanic Drugs: Overview
115
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
115
Antidepressant Drugs: Overview
351
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
351
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
280
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
280
Bipolar Disorder
45
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
45
Drug Therapy
35
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
35


